- Home
- AAME vs ARMP Comparison
AAME vs ARMP Comparison
Compare AAME & ARMP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AAME
- ARMP
- Stock Information
- Founded
- AAME 1968
- ARMP N/A
- Country
- AAME United States
- ARMP United States
- Employees
- AAME N/A
- ARMP N/A
- Industry
- AAME Life Insurance
- ARMP Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- AAME Finance
- ARMP Health Care
- Exchange
- AAME Nasdaq
- ARMP Nasdaq
- Market Cap
- AAME 46.3M
- ARMP 52.1M
- IPO Year
- AAME N/A
- ARMP N/A
- Fundamental
- Price
- AAME $2.27
- ARMP $2.39
- Analyst Decision
- AAME
- ARMP Strong Buy
- Analyst Count
- AAME 0
- ARMP 1
- Target Price
- AAME N/A
- ARMP $9.00
- AVG Volume (30 Days)
- AAME 26.5K
- ARMP 15.4K
- Earning Date
- AAME 08-13-2025
- ARMP 08-12-2025
- Dividend Yield
- AAME 0.88%
- ARMP N/A
- EPS Growth
- AAME N/A
- ARMP N/A
- EPS
- AAME N/A
- ARMP N/A
- Revenue
- AAME $191,355,000.00
- ARMP $4,699,000.00
- Revenue This Year
- AAME N/A
- ARMP $8.43
- Revenue Next Year
- AAME N/A
- ARMP N/A
- P/E Ratio
- AAME N/A
- ARMP N/A
- Revenue Growth
- AAME 2.04
- ARMP 14.24
- 52 Week Low
- AAME $1.25
- ARMP $0.90
- 52 Week High
- AAME $2.61
- ARMP $3.00
- Technical
- Relative Strength Index (RSI)
- AAME 60.63
- ARMP 59.49
- Support Level
- AAME $1.94
- ARMP $2.14
- Resistance Level
- AAME $2.28
- ARMP $2.61
- Average True Range (ATR)
- AAME 0.13
- ARMP 0.17
- MACD
- AAME 0.00
- ARMP 0.01
- Stochastic Oscillator
- AAME 81.82
- ARMP 67.65
About AAME Atlantic American Corporation
Atlantic American Corp operates in specialty markets within the life and health and property and casualty insurance industries. The company has two segments: American Southern, It provides property and casualty insurance including bodily injury and property damage liability coverage, uninsured motorist coverage, and physical damage coverage for commercial accounts, and Bankers Fidelity, the company's life and health operations offer a variety of life and supplemental health products including ordinary and term life insurance, Medicare supplement, and other health insurance.
About ARMP Armata Pharmaceuticals Inc.
Armata Pharmaceuticals Inc is a developer of pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat bacterial infections using its proprietary bacteriophage-based technology. The company is developing and advancing a broad pipeline of natural and synthetic phage candidates, including clinical candidates for Pseudomonas aeruginosa, Staphylococcus aureus, and other pathogens. In addition, in collaboration with Merck, the company is developing proprietary synthetic phage candidates to target an undisclosed infectious disease agent.